Skip to main content

Before you Buy: Check the Credit Tab to Make Sure Your Jurisdiction is Accredited!

Back to Search

On Demand

Legal Trafficking - The Global THC Supply Chain of the Future

Average Rating:
Not yet rated
Cross Border Markets & Commerce |  Regulatory |  Licensing and Permitting |  Policy
Kai-Friedrich Niermann |  Jason Moscovici |  Simon Rowell |  John Walsh |  Daniel Podestá Farina
1 Hour 09 Minutes
Audio and Video
Access for 6 month(s) after purchase.


This panel will reflect on the future trade of THC products and how such trade can function without between countries, above and beyond the existing Single Convention. We see that besides Canada and Uruguay, other countries are on the starting blocks to fundamentally change their cannabis policies. Apart from the USA, next year’s change of cannabis policy could include Germany, as there are federal elections and a new government will be highly likely. Luxembourg has already decided on legalization and New Zealand is holding a referendum on it in November this year. Not in every case the local demand will be covered by local cultivation. Domestic cultivation is not even sensible from an environmental point of view, as too much energy is consumed in northern regions. In Germany alone, the demand for dried flowers from a legal and regulated export market is estimated with 500-600 tons. If new and modern products like Vape-Pens, Edibles and Beverages are developed, some countries and regions already have a know-how advantage which predestines them for the export of the products. This session will look at how an international supply chain for recreational cannabis products can be designed and how the enormous demand for products from legal markets can be satisfied. What conditions need to be created at the level of international law to make global trade possible? And what about import duties, safety standards and Intellectual Property?



This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules. 

INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.

The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.

(Default credit disclaimer updated 02.08.2024)

For current accreditation status, please select your jurisdiction below.



Kai-Friedrich Niermann's Profile

Kai-Friedrich Niermann Related Seminars and Products



Kai is characterized by his outstanding expertise and diverse practice in the cannabis industry. With a broad range of expertise in cannabis and business law, he provides comprehensive legal support to companies and individuals.

From contract drafting and company formation to day-to-day legal support, he assists cannabis companies with customized solutions in all legal matters, including white collar criminal law where necessary.

Kai is also the author of the blog, where he positions himself as an expert in the thriving cannabis business. not only provides insights into the legal status of cannabis in Germany and Europe today, but also current developments and offers resources for businesses and interested parties.

His work spans all aspects of the cannabis industry, from advising companies on cultivation licenses and production regulations to assisting with regulatory issues in product development. His deep understanding of the complex legal framework in this sector makes him a sought-after contact.

Kai and his law firm KFN+ advise large CBD and medical cannabis companies, as well as companies and associations interested in the emerging recreational cannabis market. He is also advisor to the European Industrial Hemp Association (EIHA), which has submitted a joint application to the EU Commission for authorization as a novel food for various CBD products.

With an international perspective, Kai operates not only nationally, but also across borders. His network in the industry enables him to support companies in their global activities and adapt to the challenges of an ever-changing legal landscape.

Kai regularly speaks at international cannabis conferences on topics related to the German and European legal framework for cannabis, and publishes articles at Krautinvest, BusinessCann and in law journals.

Born in Löhne/Westf. in 1972, studied law at the Universities of Marburg, Adelaide (Australia), Cologne, legal assistant at the press center of the German Bundestag (2000-2002), worked for the Berlin District Court, for the Director of Public Prosecution in Berlin, for the Berlin Office for the Protection of the Constitution and the Hong Kong Consulate General.

Areas of Law:

  • Legal Cannabis Consulting
  • Regulatory approvals for medical cannabis and CBD
  • Business law (company, commercial and contract law) 
  • Law of torts
  • Criminal business law


Jason Moscovici's Profile

Jason Moscovici Related Seminars and Products

Partner, Lawyer, Biochemist

Robic, LLP

Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.

Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.

Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.

Simon Rowell's Profile

Simon Rowell Related Seminars and Products

IP Management and Commercialisation


Simon is the founder of Innovation Liberation Front.


Before starting Innovation Liberation Front, Simon practiced for seventeen years as a lawyer and patent attorney, spending 9 years as the partner heading the Commercialisation Team of James & Wells Intellectual Property. Much of his work involved licensing intellectual property internationally.
In 2018, 2017, 2016 and 2012 Simon was listed in Intangible Asset Management magazine’s IAM Strategy 300 – the World’s Leading IP Strategists and IAM Patent 1000 – Guide to the World’s Leading Patent Practitioners.


Simon is well versed in the needs of entrepreneurial growth companies, and has been himself involved as a co-founder or investor and advisor in several startups. These include Magic Mitten Limited, which invented the product now marketed as GroHush by The Gro Company in 30 countries around the world; Nutrient Rescue, which manufactures and markets nutritional plant powders; Ligar LP, which develops molecularly imprinted polymers for specific extraction needs; and Sagitto, which provides data science as a service based on handheld NIR scanners to characterise oils, textiles, plastics and other substances.

John Walsh's Profile

John Walsh Related Seminars and Products

Director for Drug Policy

Washington Office on Latin America (WOLA)

Mr. Walsh has written extensively on the need to reassess drug policy goals, strategies, and indicators, focused on limits and harms of supply-control efforts under a prohibitionist framework. Connecting domestic U.S. reforms to the international drug policy debate, Walsh has worked extensively on the implication of cannabis legalization for the prohibtiionist UN drug contorl treaties, co-authoring the report “Balancing Treaty Stability and Change: Inter se modification of the UN drug control conventions to facilitate cannabis regulation." His work has contributed to the expansion of the international drug policy reform debate, and been instrumental in convening reform advocates and practitioners from across the hemisphere to discuss design and evaluation of legal, regulated cannabis.

A frequent commentator on drug policy developments in the U.S. and Latin America, Mr. Walsh has been quoted in The New York Times, The Washington Post, The Wall Street Journal, The Associated Press, National Public Radio, and numerous television and international news outlets. In addition to his congressional testimony, publications, press appearances, Mr. Walsh has organized and spoken at numerous U.S. and international conferences. Prior to joining WOLA, he served as director of research at Drug Strategies and worked at the Center of Concern on the “Rethinking Bretton Woods Project,” an effort to forge consensus on ideas for reform of the World Bank, the International Monetary Fund, and international trade arrangements.


He received a B.A. in Theology from Georgetown University (1986) and an M.A. in Public Policy from the Johns Hopkins University (1997).

Daniel Podestá Farina's Profile

Daniel Podestá Farina Related Seminars and Products

Uruguay Lawyer

Estudio Podestá

Daniel is a lawyer with more than eighteen years of experience. Actually, he is partner at Estudio Podestá, law firm founded in 1978.

Since 2013, he has specialized in regulatory framework of hemp and cannabis industries in Uruguay, advising companies -from startups to large publicly listed companies- throughout the process of obtaining licenses and authorizations before public authorities and counselling them in corporate matters and M&A.

Daniel has assisted companies that have marked the most important milestones in the cannabis sector in Uruguay:

 -First company to obtain license for cultivation and commercialization of recreational cannabis granted by the State.

-First company to register before the National Seed Institute of a hemp variety developed locally.

-First company to industrialize and commercialize an edible -yerba mate- with the addition of cannabis.

-First company to industrialize and commercialize a pharmaceutical cannabis-based product. 

- First company to obtain authorization for an animal feed product with the addition of cannabis.

-First company to export hemp flowers and open the exports markets for Uruguay.

-First National Agrarian Association of hemp producers.

On October 2018 Daniel was appointed as General Secretary of the Chamber of Medicinal Cannabis Companies for the period 2018-2021.

Due to his extensive knowledge of regulatory framework of the industry has exposed as speaker and panelist at conferences in Canada, Spain and the United States.

He has actively collaborated with the Uruguayan government in drafting local regulations being source of consultation for governments of the southern hemisphere.

He is the author of publications in various specialized industry media.

Alternate Options

Global Perspectives of Legalization
Original Program Date: 10/13/2020 - SKU INCBA101320GL
Defining Access: Medical, Adult, OTC, or Something Else?
Original Program Date: 10/13/2020 - SKU INCBA101320DE
Import / Export: The Cross Border Hemp Trade
Original Program Date: 10/15/2020 - SKU INCBA101520IM